Literature DB >> 12661845

Evaluation of FASTPlaqueTB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates.

O Kisa1, A Albay, O Bedir, O Baylan, L Doganci.   

Abstract

SETTING: The Microbiology and Clinical Microbiology Department, Gulhane Military Medical Academy, Ankara, Turkey, a tertiary referral hospital in a region endemic for tuberculosis.
OBJECTIVE: To evaluate rifampicin resistance of Mycobacterium tuberculosis complex strains using FASTPlaqueTB-RIF, a rapid and novel bacteriophage-based susceptibility technique.
DESIGN: Results of isolates tested with the BACTEC 460 TB system were compared with FASTPlaqueTB-RIF.
RESULTS: Susceptibility to rifampicin of M. tuberculosis complex isolates was tested for 88 isolates using FASTPlaqueTB-RIF. Sixty-seven isolates were susceptible and 21 were resistant to rifampicin using the BACTEC 460 TB system. Overall accuracy for FASTPlaqueTB-RIF was 94.3% (95%CI 87.3-97.5) for the detection of rifampicin susceptibility. The sensitivity and specificity of FASTPlaqueTB-RIF were respectively 100.0% (95%CI 84.5-100) and 92.5% (95%CI 83.6-96.7).
CONCLUSION: This study demonstrates that FASTPlaqueTB-RlFM is a rapid and inexpensive test which has a good correlation with the BACTEC 460 TB system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12661845

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  2 in total

1.  In-house phage amplification assay is a sound alternative for detecting rifampin-resistant Mycobacterium tuberculosis in low-resource settings.

Authors:  Norberto Símboli; Howard Takiff; Ruth McNerney; Beatriz López; Anandi Martin; Juan Carlos Palomino; Lucía Barrera; Viviana Ritacco
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  Real-time PCR using mycobacteriophage DNA for rapid phenotypic drug susceptibility results for Mycobacterium tuberculosis.

Authors:  Suporn Pholwat; Beeta Ehdaie; Suporn Foongladda; Kimberly Kelly; Eric Houpt
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.